How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,264 results for

("novel coronavirus" OR COVID OR CoV-2) (pediatric OR paediatric OR child OR children OR youth OR adolescent)

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Scientific Brief: Multisystem inflammatory syndrome in children and adolescents with COVID-19

adults. Pediatr Pulmonol. 2020;55(5):1169-74. Epub 2020/03/07 Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA. 2020. Epub 2020/02/15 Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020;382(17):1663-5. Epub 2020/03/19 Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (...) . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. Epub 2020/03/15 Cai J, Xu J, Lin D, Yang Z, Xu L, Qu Z, et al. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020. Epub 2020/03/01 Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from

2020 WHO Coronavirus disease (COVID-19) Pandemic

2. ACR Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID?19. Version 1 Full Text available with Trip Pro

ACR Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID?19. Version 1 American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV2 and Hyperinflammation in COVID‐19. Version 1 - Henderson - - Arthritis & Rheumatology - Wiley Online Library Working off-campus? Learn about our By continuing (...) to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term FULL LENGTH Free Access American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV2 and Hyperinflammation in COVID‐19. Version 1 Corresponding Author E-mail address: Division of Immunology, Boston Children’s Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA

2020 American College of Rheumatology

3. British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) Coronavirus (SARS-CoV-2) and COVID-19 in children with Inflammatory Bowel British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) Coronavirus (SA

British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) Coronavirus (SARS-CoV-2) and COVID-19 in children with Inflammatory Bowel British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) Coronavirus (SA 1 IBD Working Group British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) Coronavirus (SARS-CoV-2) and COVID-19 in children with IBD Position Statement: Management of PIBD during the SARS-CoV-2 pandemic Specific (...) guidance on how to manage children and adolescents with IBD during the current SARS-CoV-2 pandemic has been difficult to develop given the frequently changing government advice for the general public [1] and lack of pandemic specific data for PIBD. More recently however, the British Society of Gastroenterology (BSG) has published a disease risk stratification to help providing specific advice for IBD patients taking disease status and medical therapy into account [2]. In addition, the first

2020 British Society of Paediatric Gastroenterology Hepatology and Nutrition

4. What paediatricians can do to support children and youth during the COVID-19

reviewed by the Adolescent Health and Community Paediatrics Committees and the Child and Youth Maltreatment Section Executive of the Canadian Paediatric Society. Shazeen Suleman, Yasmine Ratnani, Christine Loock, Katrina Stockley, Susan Bennett, Radha Jetty, Katharine Smart, Sarah Gander; Canadian Paediatric Society, Social Paediatrics Section References Gupta RP, de Wit ML, McKeown D. The impact of poverty on the current and future health status of children. Paediatr Child Health 2007;12(8):667–72 (...) What paediatricians can do to support children and youth during the COVID-19 What paediatricians can do to support children and youth during the COVID-19What paediatricians can do to support children and youth during the COVID-19 | Canadian Paediatric Society A home for paediatricians. A voice for children and youth. Current: What paediatricians can… Practice Point What paediatricians can do to support children and youth during the COVID-19 Posted: May 5, 2020 The Canadian Paediatric Society

2020 Canadian Paediatric Society

5. Current epidemiology and guidance for COVID-19 caused by SARS-CoV-2 virus, in children: March 2020

-CoV-2 virus, in children: March 2020 Posted: Mar 25 2020 The Canadian Paediatric Society gives permission to print single copies of this document from our website. For permission to reprint or reproduce multiple copies, please see our . Principal author(s) Nicole Le Saux, Canadian Paediatric Society, The emergence in December 2019 of COVID-19, caused by a novel coronavirus, and its subsequent spread around the world, led the World Health Organization to declare a pandemic on March 11, 2020 (...) Current epidemiology and guidance for COVID-19 caused by SARS-CoV-2 virus, in children: March 2020 Current epidemiology and guidance for COVID-19 caused by SARS-CoV-2 virus, in children: March 2020Current epidemiology and guidance for COVID-19 caused by SARS-CoV-2 virus, in children: March 2020 | Canadian Paediatric Society A home for paediatricians. A voice for children and youth. Current: Current epidemiology and… Practice Point Current epidemiology and guidance for COVID-19 caused by SARS

2020 Canadian Paediatric Society

6. COVID-19 (Novel Coronavirus)

by a novel coronavirus (SARS-CoV-2) first identified in December 2019 in Wuhan, Hubei Province, China and spreading worldwide ( ) PubMed 32123347 Nature microbiology Nat Microbiol 20200302 SARS-CoV-2 is a member of beta genus coronaviruses closely related to SARS-CoV ( ) common signs of COVID-19 include fever, cough, and shortness of breath ( ) there is no specific antiviral treatment for COVID-19, but supportive care may help to relieve symptoms and should include support of vital organ functions (...) in severe cases ( ) Also Called SARS-CoV-2 2019-nCoV Wuhan Virus Wuhan novel coronavirus (WN-CoV) Definitions World Health Organization (WHO) case definitions for surveillance based on current information available and may be revised as new information accumulates suspect case - any of patient with severe acute respiratory infection (fever plus ≥ 1 sign or symptom of respiratory disease) requiring admission to hospital without another etiology that fully explains clinical presentation patient with acute

2020 DynaMed Plus

7. Healthcare worker perception of a global outbreak of novel coronavirus (COVID-19) and personal protective equipment: Survey of a pediatric tertiary-care hospital. Full Text available with Trip Pro

Healthcare worker perception of a global outbreak of novel coronavirus (COVID-19) and personal protective equipment: Survey of a pediatric tertiary-care hospital. In this study, we aimed to capture perspectives of healthcare workers (HCWs) on coronavirus disease 2019 (COVID-19) and infection prevention and control (IPAC) measures implemented during the early phase of the COVID-19 pandemic.A cross-sectional survey of HCWs.HCWs from the Hospital for Sick Children, Toronto, Canada.A self (...) -administered survey was distributed to HCWs. We analyzed factors influencing HCW knowledge and self-reported use of personal protective equipment (PPE), concerns about contracting COVID-19 and acceptance of the recommended IPAC precautions for COVID-19.In total, 175 HCWs completed the survey between March 6 and March 10: 35 staff physicians (20%), 24 residents or fellows (14%), 72 nurses (41%), 14 respiratory therapists (8%), 14 administration staff (8%), and 14 other employees (8%). Most

2020 Infection control and hospital epidemiology

8. Rapid risk assessment: Paediatric inflammatory multisystem syndrome and SARS -CoV-2 infection in children

Rapid risk assessment: Paediatric inflammatory multisystem syndrome and SARS -CoV-2 infection in children Risk assessment 15 May 2020 Cite: European Centre for Disease Prevention and Control. Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children – 15 May 2020. ECDC: Stockholm; 2020. Several countries affected by the coronavirus disease (COVID-19) pandemic recently reported cases of children that were hospitalised in intensive care due to a rare paediatric inflammatory (...) of this new paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS) have been reported in EU/EEA countries and the UK in 2020, including two fatalities, one in the UK and one in France. These cases are being further investigated. So far, epidemiological studies have shown that children appear to be less affected by COVID-19. Only 2.1% of all laboratory-confirmed COVID-19 cases reported to The European Surveillance System (TESSy) were in the age group between

2020 European Centre for Disease Prevention and Control - Technical Guidance

9. Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children

a number of seriously ill children presenting with signs of circulatory shock and hyperinflammatory state, with features consistent with toxic shock or KD (Table 1). Some of the tested children also were positive for SARS-CoV-2 infection. A case of classic KD with concurrent COVID-19 had already been reported on 7 April in the United States [3]. On 1 May, the Royal College of Paediatrics and Child Health published guidance on the clinical management of children with a presentation of paediatric (...) by the coronavirus disease (COVID-19) pandemic recently reported cases of children that were hospitalised in intensive care due to a rare paediatric inflammatory multisystem syndrome (PIMS). The presenting signs and symptoms are a mix of the ones for Kawasaki disease (KD) and toxic shock syndrome (TSS) and are characterised, among others, by fever, abdominal pain and cardiac involvement. A possible temporal association with SARS-COV-2 infection has been hypothesised because some of the children that were tested

2020 ICM Anaesthesia COVID-19

10. Clinical Guidance Summary for Pediatric Patients with MIS-C Associated with SARS-CoV-2 and Hyperinflammation in COVID-19

Clinical Guidance Summary for Pediatric Patients with MIS-C Associated with SARS-CoV-2 and Hyperinflammation in COVID-19 1 Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19 Developed by the ACR MIS-C and COVID-19 Related Hyperinflammation Task Force This draft summary was approved by the ACR Board of Directors on June 17, 2020. A full paper was published on July 23, 2020.* Purpose (...) definition of MIS-C because several already exist. Instead, the Task Force focused on consensus building to identify the most appropriate diagnostic and therapeutic steps that providers should consider at the present time. The Task Force also provided recommendations for children with hyperinflammation during COVID-19, the acute, infectious phase of SARS-CoV-2 infection. Given that our understanding of SARS-CoV-2-related syndromes in the pediatric population continues to evolve, this guidance document

2020 American College of Rheumatology

11. Infection prevention and control for novel coronavirus (COVID-19): interim guidance for acute healthcare settings

, and MERS coronavirus. On January 10, 2020, a novel coronavirus, now referred to as SARS-CoV-2 was identified as the cause of the outbreak of pneumonia. Publication of the genetic sequencing of the SARS-CoV-2 has enabled the development of laboratory tests to specifically identify the virus. The outbreak has since spread beyond the city of Wuhan, with laboratory-confirmed cases identified in multiple municipalities and provinces within China. Cases have also been confirmed outside of mainland China (...) Infection prevention and control for novel coronavirus (COVID-19): interim guidance for acute healthcare settings Infection prevention and control for coronavirus disease (COVID-19): Interim guidance for acute healthcare settings - Canada.ca Language selection Search Search Canada.ca Search Menu Main Menu You are here: Infection prevention and control for coronavirus disease (COVID-19): Interim guidance for acute healthcare settings Table of Contents Introduction The Public Health Agency

2020 CPG Infobase

12. Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community

for longer in the immunocompromised and pediatric populations. Two negative swabs, collected at least 24 hours apart, AND resolution of acute symptoms are required to rule out communicability and discontinue isolation DIAGNOSTIC TESTING PCR developed at BCCDC PHL Up to date lab testing guidelines can be found on the BCCDC Health Professionals page: http://www.bccdc.ca/health-professionals/clinical-resources/novel-coronavirus-(covid-19) SURVEILLANCE AND REPORTING Case definitions have been developed (...) Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community Interim Guidance: Public Health Management of cases and contacts associated with novel coronavirus (COVID-19) in the community March 10, 2020 CONTEXT The British Columbia Centre for Disease Control (BCCDC) has adapted the interim guidance from the Public Health Agency of Canada (PHAC) for Regional Health Authorities (RHA) for public health management of human illness

2020 CPG Infobase

13. Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 1

Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 1 MED CHECK April 2020/ Vol.6 No.16 · Page C N o 16 M ED HECK 2 0 2 0 Editorial The Plague (La Peste in French) Urgent Recommendations Five Don'ts to Prevent COVID-19 and Death Editorial The Plague (La Peste in French) Urgent Recommendations Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death 1. Don't use ibuprofen or other NSAIDs 2. Don't use corticosteroids especially in the early phase (...) of Albert Camus (November 7, 1913-January 4, 1960), a novel written in 1947, shortly after the end of World War II. It predicts the status of the current world being swept by the pandemic of the novel coronavirus infection (COVID-19). I read it for the first time when I was in the second grade of junior high school. It's been a long time, but a strange feeling after reading was completely different from other masterpieces I read in those days and has remained in my memory. The second time I read

2020 Med Check - The Informed Prescriber

14. Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 2

season, flu was not very prevalent due to the unusually warm winter. However, a case has been confirmed in which a medical doctor who conducted a rapid testing for a patient suspected influenza was infected with a novel coronavirus (SARS-CoV-2 or COVID-19 virus), because the patient was found infected with SARS-CV-2 later. Therefore, the Japan Medical Association recommended member doctors against testing even in case with suspected flu and recommended diagnosis based on the clinical symptoms [8 (...) injured tissues attaching ACE2 (1) SARS-CoV-2 attach ACE2 to enter the body to systemic dissemination Not only the novel coronavirus (SARS-CoV-2 or COVID-19 virus) [20-22] and SARS-CoV that emerged in 2003 [23] but also non-SARS-CoV [24] infect the human body using an enzyme called angiotensin converting enzyme-2 (ACE2). . As we have seen in the previous section, elderly people are more susceptible to COVID-19, especially those with chronic diseases. These may be deeply related. Let’s explain how

2020 Med Check - The Informed Prescriber

15. Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care

Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care Health Protection Scotland This document is uncontrolled when printed. Before use check the HPS COVID-19 page to verify this is the current version Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care Version 10.4 Publication date 27 March 2020 Health Protection Scotland 1 Version History Version Date Summary of changes V1.0 23/01/20 First (...) equipment 12 11.5. Carpeted flooring and soft furnishings 12 11.6. On leaving the room 13 11.7. Cleaning of communal areas 13 11.8. Attending deaths 13 12. Further information 13 Appendix 1: Contact details for local Health Protection Teams 14 Health Protection Scotland 4 Appendix 2: Putting on and removing Personal Protective Equipment (PPE) 15 Instructional video 16 Health Protection Scotland 5 1. Introduction Novel coronavirus (COVID-19) is a new is a new strain of coronavirus first identified

2020 Covid-19 Ad hoc guidelines

16. Pediatric COVID-19: a systematic review of children and adolescents with SARS-CoV-2 infection

Pediatric COVID-19: a systematic review of children and adolescents with SARS-CoV-2 infection Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2020 PROSPERO

17. Vaccine recommendations for children and youth for the 2020/2021 influenza season

Vaccine recommendations for children and youth for the 2020/2021 influenza season The Canadian Paediatric Society continues to encourage annual influenza vaccination for ALL children and youth 6 months of age and older. Recommendations from the National Advisory Committee on Immunization (NACI) for the 2020/2021 influenza season are not substantially changed from those of last season except for permitting the use of live attenuated influenza vaccine in selected children with well-controlled HIV (...) infection. Quadrivalent vaccine, if available, is recommended for children 6 months to 17 years of age. Either inactivated influenza vaccine or live attenuated influenza vaccine may be used for children and youth 2 to 17 years of age who are not immunocompromised. LAIV will again be available in Canada for the 2020/2021 season. NACI has also addressed issues related to provision of influenza vaccine during the COVID-19 pandemic. Keywords:   Children; COVID-19; Influenza vaccine; Inactivated

2020 Canadian Paediatric Society

18. NCCP guidance for Medical Professionals for testing COVID-19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus pandemic

NCCP guidance for Medical Professionals for testing COVID-19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus pandemic Version: 2.00 Department: NCCP COVID-19 Surgical testing group Update date: 04/06/2020 Code: SO_COVID19_3 Revision date: 1 NCCP guidance for Medical Professionals for testing COVID- 19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus pandemic This document relates (...) ://www.gov.ie/en/campaigns/c36c85-covid-19- coronavirus/ ? Ireland’s National Action Plan in response to COVID-19 (Coronavirus) - https://www.gov.ie/en/campaigns/c36c85-covid-19-coronavirus/ Version: 2.00 Department: NCCP COVID-19 Surgical testing group Update date: 04/06/2020 Code: SO_COVID19_3 Revision date: 2 2 Purpose The purpose of this guidance document is to provide guidance for testing COVID-19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus

2020 Health Service Executive (Ireland) - Clinical Guidelines

19. Novel Coronavirus 2019 (COVID-19)

Novel Coronavirus 2019 (COVID-19) Novel Coronavirus 2019 (COVID-19) | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Novel Coronavirus 2019 (COVID-19) Practice Advisory March 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions. . The Centers for Disease Control and Prevention (CDC) has released and guidance for . Travel Due to the current risk of COVID-19, CDC (...) women. For more information on seasonal influenza and recommendations for pregnant women see the and . The American College of Obstetricians and Gynecologists will continue to closely monitor the evolution of the 2019 novel coronavirus (COVID-19) in collaboration with the CDC. New and updated information will be shared as it becomes available. This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization, Infectious Disease, and Public Health

2020 American College of Obstetricians and Gynecologists

20. Treatment of Depression in Children and Adolescents

for childhood depression, clinicians contend with sparse evidence and are concerned about harms associated with treatment. Methods. We conducted a systematic review to evaluate the efficacy, comparative effectiveness, and moderators of benefits and harms of available nonpharmacological and pharmacological treatments for children and adolescents with a confirmed diagnosis of a depressive disorder (DD)—major depressive disorder (MDD), persistent depressive disorder (previously termed dysthymia) or DD (...) to harm for interventions for childhood depression 137 Table 68. Evidence map for interventions for childhood depression Error! Bookmark not defined. Figures Figure A. Analytic framework for depression in children and adolescents ES-3 Figure B. Article flow diagram ES-6 Figure 1. Analytic framework for depression in children and adolescents 6 Figure 2. Article flow diagram 15 Appendixes Appendix A. Search Strategy Appendix B. Inclusion/Exclusion Criteria Appendix C. Excluded Studies Appendix D. Study

2020 Effective Health Care Program (AHRQ)

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>